Chinese english Germany Japanese Korea

14,15-Dehydro Budesonide

14,15-Dehydro Budesonide Struktur
131918-64-4
CAS-Nr.
131918-64-4
Englisch Name:
14,15-Dehydro Budesonide
Synonyma:
Budesonide iMpurit E;Budesonide impurity E;14,15-Dehydro Budesonide;Budesonide EP Impurity E;Budesonide Impurity F (14,15 Dehydro Budes.);Budesonide EP Impurity E, Related Compound E;Budesonide Impurity 5(Budesonide EP Impurity E);Budesonide EP Impurity E (14,15-Dehydro Budesonide);Budesonide EP Impurity-E/ Budesonide Related Compund E(14,15-Dehydro Budesonide);16α,17-[(1RS)-Butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione
CBNumber:
CB12543045
Summenformel:
C25H32O6
Molgewicht:
428.52
MOL-Datei:
131918-64-4.mol
Request For Quotation

14,15-Dehydro Budesonide Eigenschaften

Schmelzpunkt:
132-134°C
Siedepunkt:
612.4±55.0 °C(Predicted)
Dichte
1.30±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer
Löslichkeit
Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly)
pka
12.82±0.10(Predicted)
Aggregatzustand
Solid
Farbe
White to Pale Yellow

Sicherheit

HS Code  2937290000

14,15-Dehydro Budesonide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

14,15-Dehydro Budesonide (Budesonide EP Impurity E) is a Budesonide (B689490) impurity.

14,15-Dehydro Budesonide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

14,15-Dehydro Budesonide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 60)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Career Henan Chemica Co 		+86-0371-86658258 15093356674;
 laboratory@coreychem.com China 30255 58
sgtlifesciences pvt ltd 		+8617013299288
 dj@sgtlifesciences.com China 12382 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd 		+8618829768577
 gao490372054@gamil.com China 1250 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Guangzhou Tosun Pharmaceutical Limited 		+8618922120635
 sales@toref-standards.com China 1000 58
LEAPCHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 43348 58
Guangzhou PI PI Biotech Inc +86-020-81716320 +86-13602409664
 Sales@pipitech.com China 3635 55
hubei PharmaStandard Co., Ltd. 027-19050701 13545374703
 cbbspring@163.com China 323 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
 jkinfo@jkchemical.com China 96815 76

131918-64-4()Verwandte Suche:

16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion 11β,16α,17,21-Tetrahydroxypregna-1,4-dien-3,20-dion Desonid Budesonid
  • 14,15-Dehydro Budesonide
  • (11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4,14-triene-3,20-dione
  • Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-tri (1078245)
  • 16α,17-[(1RS)-Butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione
  • Budesonide EP Impurity-E/ Budesonide Related Compund E(14,15-Dehydro Budesonide)
  • (6aR,6bS,7S,8aS,8bS,11aR,12bR)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
  • Pregna-1,4,14-triene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11β,16α)-
  • Budesonide iMpurit E
  • Budesonide Impurity F (14,15 Dehydro Budes.)
  • Budesonide EP Impurity E (14,15-Dehydro Budesonide)
  • Budesonide Impurity 5(Budesonide EP Impurity E)
  • Budesonide impurity E
  • 16α,17-[(1RS)-butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione
  • Budesonide EP Impurity E
  • (6aR,6bS,7S,8aS,8bS,11aR,12bR)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (Budesonide Impurity）
  • Budesonide EP Impurity E, Related Compound E
  • 131918-64-4
  • Pharmaceuticals, Intermediates & Fine Chemicals, Steroids
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Steroids
Copyright 2019 © ChemicalBook. All rights reserved